www.uhasselt.be
DSpace

Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/23939

Title: Teri-DYNAMIC: Exploring the impact of teriflunomide on immune cell population size, receptor repertoire, and function in patients with RRMS
Authors: Wiendl, Heinz
Gross, Catharina C.
Eschborn, Melanie
Weisser, Linda
Posevitz-Fejfar, Anita
Schulte-Mecklenbeck, Andreas
Van Wijmeersch, Bart
Hupperts, Raymond
Brette, Sandrine
Turner, Timothy J.
Bar-Or, Amit
Klotz, Luisa
Issue Date: 2017
Publisher: SAGE PUBLICATIONS LTD
Citation: MULTIPLE SCLEROSIS JOURNAL, 23(1), p. 144-144 (Art N° 69)
Abstract: Teriflunomide, an immunomodulator approved for patients with relapsing forms of MS, specifically inhibits proliferation of activated lymphocytes. Teri-DYNAMIC (NCT01863888) characterized the immunomodulatory effects of teriflunomide treatment on lymphocyte subsets in patients with relapsing–remitting multiple sclerosis (RRMS). Objectives: To explore the immunomodulatory effects of teriflunomide on lymphocyte subsets, receptor repertoire, and function in patients with RRMS.
Notes: [Wiendl, H.; Gross, C. C.; Eschborn, M.; Weisser, L.; Fejfar, A. Posevitz; Mecklenbeck, A. Schulte; Klotz, L.] Univ Munster, Munster, Germany. [Van Wijmeersch, B.] Hasselt Univ, Hasselt, Belgium. [Hupperts, R.] Maastricht Univ, Med Ctr, Orbis Med Ctr, Maastricht, Netherlands. [Brette, S.] Lincoln, Boulogne, France. [Turner, T. J.] Sanofi Genzyme, Cambridge, MA USA. [Bar-Or, A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
URI: http://hdl.handle.net/1942/23939
DOI: 10.1177/1352458516666193
ISI #: 000393906000059
ISSN: 1352-4585
Category: M
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
N/A640.14 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.